VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TMOThermo Fisher Scientific Inc.
$464.61$172.7B
Research
OverviewAnalysisShould I Buy?
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTMOPrice Target
TMO logo

Thermo Fisher Scientific Inc. (TMO) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Buy
Based on 42 analysts

29.1% Below Target

TMO trades 29.1% below Wall Street's consensus target of $599.70.

Current Price$464.61
Average Target$599.70
Target
Current
Low$490.00
Median$617.50
High$683.00

Analyst Target Range

Forward P/E18.7x
(Fair)
PEG Ratio8.85
(Expensive)
Implied Growth+35.2%
(High Growth)
Analyst Spread32.2%
(Moderate)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$464.61
Consensus$599.70
High$683.00
Low$490.00

Consensus Scenario Assumptions

The base valuation assumes TMO achieves its forward estimates and maintains a stable P/E multiple of 18.7x. This scenario reflects the blended consensus of 42 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 42 published analyst recommendations for TMO

37/42 analysts are bullish
+44
BearishBullish
Weighted analyst sentiment score based on 42 ratings
ConsensusBuy
Coverage42 Analysts
Net Score+44
Bull / Bear88% / 0%
Strong Buy00%
Buy3788%
Hold512%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
3788%
Hold
512%
Sell
00%
Strong Sell
00%
Recommendation Mix88% Buy · 12% Hold · 0% Sell
Buy (37)Hold (5)Sell (0)

TMO Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, Thermo Fisher Scientific Inc. (TMO) has a Wall Street consensus price target of $599.70, based on estimates from 42 covering analysts. With the stock currently trading at $464.61, this represents a potential upside of +29.1%. The company has a market capitalization of $172.66B.

Analyst price targets range from a low of $490.00 to a high of $683.00, representing a 32% spread in expectations. The median target of $617.50 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 37 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, TMO trades at a trailing P/E of 26.2x and forward P/E of 18.7x. The forward PEG ratio of 8.85 reflects a premium valuation. Analysts expect EPS to grow +35.2% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $620.89, with bear and bull scenarios of $391.16 and $818.08 respectively. Model confidence stands at 53/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+26.8%
Industry Consensus
Avg Forward P/E
22.9x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
DHR logo
DHRDanaher Corporation
$125.4B$177.17$230.89
+30.3%
Buy21.0x43
A logo
AAgilent Technologies, Inc.
$35.9B$127.06$154.75
+21.8%
Buy21.0x41
WAT logo
WATWaters Corporation
$23.2B$355.44$395.25
+11.2%
Hold24.5x35
BIO logo
BIOBio-Rad Laboratories, Inc.
$7.6B$282.44$321.67
+13.9%
Buy31.2x14
BRKR logo
BRKRBruker Corporation
$8.7B$57.23$47.67
-16.7%
Buy27.0x32
MTD logo
MTDMettler-Toledo International Inc.
$23.1B$1144.84$1392.25
+21.6%
Hold24.5x19
IQV logo
IQVIQVIA Holdings Inc.
$28.5B$167.77$219.44
+30.8%
Buy13.1x44
CRL logo
CRLCharles River Laboratories International, Inc.
$8.9B$185.00$214.14
+15.8%
Buy16.7x37
MEDP logo
MEDPMedpace Holdings, Inc.
$13.1B$460.20$498.86
+8.4%
Hold27.1x19
NVCR logo
NVCRNovoCure Limited
$1.6B$14.28$33.00
+131.1%
Buy—15

TMO — Frequently Asked Questions

Quick answers to the most common questions about buying TMO stock.

What is the TMO stock price target for 2026?

The consensus Wall Street price target for TMO is $599.7, representing 29.1% upside from the current price of $464.61. With 42 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is TMO a buy, sell, or hold?

TMO has a consensus rating of "Buy" based on 42 Wall Street analysts. The rating breakdown is predominantly bullish, with 37 Buy/Strong Buy ratings. The consensus 12-month price target of $599.7 implies 29.1% upside from current levels.

Is TMO stock overvalued or undervalued?

With a forward P/E of 18.6924x, TMO trades at a relatively low valuation. The consensus target of $599.7 implies 29.1% appreciation, suggesting meaningful undervaluation.

How high can TMO stock go?

The most bullish Wall Street analyst has a price target of $683 for TMO, while the most conservative target is $490. The consensus of $599.7 represents the median expectation. Our quantitative valuation model projects a bull case target of $818 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover TMO stock?

TMO is heavily covered by Wall Street, with 42 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 37 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the TMO stock forecast?

The 12-month TMO stock forecast based on 42 Wall Street analysts shows a consensus price target of $599.7, with estimates ranging from $490 (bear case) to $683 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $621, with bear/bull scenarios of $391/$818.

What is TMO's fair value based on fundamentals?

Our quantitative valuation model calculates TMO's fair value at $621 (base case), with a bear case of $391 and bull case of $818. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

What is TMO's forward P/E ratio?

TMO trades at a forward P/E ratio of 18.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 26.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy TMO stock?

Wall Street analysts are very optimistic on TMO, with a "Buy" consensus rating and $599.7 price target (29.1% upside). 37 of 42 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do TMO price targets vary so much?

TMO analyst price targets range from $490 to $683, a 32% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $599.7 consensus represents the middle ground. Our model's $391-$818 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into TMO consensus models and risk factors.

View Analysis

Should I Buy TMO?

Wall Street verdict, signals, and target summaries.

See Verdict

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare